Adlai Nortye News, Adlai Nortye Quote, ANL Quote

Adlai Nortye (NQ:ANL) Delayed: 8.91 -0.33 (3.57%)

Prev. Close

$9.24

Today 6M 1Y 5Y

Open

$9.24

52 Wk High

$22.89

52 Wk Low

$1.85

Day High

$9.80

Day Low

$8.65

P/E

N/A

EPS

$-0.06

Volume

175,179

Friends, Peers and Foes (?): BNAI, DBRG SOPA (more...)

ALERTS | RSS

Feb 13, 2026 09:38 AM H.C. Wainwright Upgrades Adlai Nortye Ltd. (ANL) to Buy
Feb 12, 2026 06:06 AM Form 6-K Adlai Nortye Ltd. For: Feb 12
Feb 12, 2026 04:00 AM Adlai Nortye doses first patient in phase 1 trial of cancer drug AN9025
Feb 12, 2026 04:00 AM Adlai Nortye Announces First Patient Enrolled in Global Phase 1 Trial of Pan-RAS (ON) Inhibitor AN9025 for Solid Tumors Harboring RAS Mutations
Feb 11, 2026 05:12 PM Form SCHEDULE 13G Adlai Nortye Ltd. Filed by: Venrock Healthcare Capital Partners III, L.P.
Feb 9, 2026 06:13 AM Form SCHEDULE 13G/A Adlai Nortye Ltd. Filed by: Unique Mark Ventures Ltd
Feb 3, 2026 04:31 PM Form 6-K Adlai Nortye Ltd. For: Feb 03
Feb 3, 2026 07:00 AM Adlai Nortye raises $140 million in private placement financing
Feb 3, 2026 07:00 AM Adlai Nortye Announces $140.0 Million Private Placement Equity Financing
Jan 29, 2026 06:05 AM Lucid Capital Markets Starts Adlai Nortye Ltd. (ANL) at Buy

Entities mentioned with ANL

View All Entities